Literature DB >> 34394208

Proteomic characterization of Naja mandalayensis venom.

Emídio Beraldo1,2, Guilherme Rabelo Coelho1, Juliana Mozer Sciani3, Daniel Carvalho Pimenta1.   

Abstract

BACKGROUND: Naja mandalayensis is a spitting cobra from Myanmar. To the best of our knowledge, no studies on this venom composition have been conducted so far. On the other hand, few envenomation descriptions state that it elicits mainly local inflammation in the victims' eyes, the preferred target of this spiting cobra. Symptoms would typically include burning and painful sensation, conjunctivitis, edema and temporary loss of vision.
METHODS: We have performed a liquid-chromatography (C18-RP-HPLC) mass spectrometry (ESI-IT-TOF/MS) based approach in order to biochemically characterize N. mandalayensis venom.
RESULTS: A wide variety of three-finger toxins (cardiotoxins) and metallopeptidases were detected. Less abundant, but still representative, were cysteine-rich secretory proteins, L-amino-acid oxidases, phospholipases A2, venom 5'-nucleotidase and a serine peptidase inhibitor. Other proteins were present, but were detected in a relatively small concentration.
CONCLUSION: The present study set the basis for a better comprehension of the envenomation from a molecular perspective and, by increasing the interest and information available for this species, allows future venom comparisons among cobras and their diverse venom proteins.

Entities:  

Keywords:  Enzymes; Naja mandalayensis; Proteome; SVMP; Spitting cobra; Three-finger toxins

Year:  2021        PMID: 34394208      PMCID: PMC8331017          DOI: 10.1590/1678-9199-JVATITD-2020-0125

Source DB:  PubMed          Journal:  J Venom Anim Toxins Incl Trop Dis        ISSN: 1678-9180


Background

Naja mandalayensis is a spitting cobra described for the first time in 2000 by Slowinski and Wüster [1], which is endemic in the central region of Myanmar, covering the Mandalay, Magwe and Sagaing regions. Its distribution corresponds to the dry zone of Myanmar, originally an Acacia savanna that is currently an agricultural region. However, this species has adapted and thrived in the agricultural fields and village surroundings. Naja mandalayensis belongs to a parafiletic group that comprises N. mossambica, N. annulifera and it is closer to N. siamensis, N. kaouthia and N. atra. [1]. The first description of a N. mandalayensis envenoming was published by a Myanmar research group that reported eight patients that were spat in the eyes by this venomous snake. Patients reported a burning and painful sensation (ophthalmia) and presented conjunctivitis, edema and temporary loss of vision [2, 3]. This is very similar to the N. mossambica accident, whose venom, when in contact with eyes, induces lacrimation, blepharospasm, conjunctivitis, keratitis and iritis miosis or mydriasis, symptoms related to inflammatory and cytotoxic compounds [4]. Slowinski, in the year 2000, published a letter depicting a self-accident with a N. mandalayensis specimen that spat venom directly to the author’s eyes inducing a burning painful reaction, and conjunctivitis, according to the report [1]. Despite the lack of reports on N. mandalayensis accidents, they remain a serious public health issue in Myanmar, as the snakebite incidence is high, and 70% of the population live in rural areas. Treatment for these patients is mainly based on antivenom administration (although traditional methods, such as herbal medicines, electric shock and suction are still being used). Regardless of the availability of antivenoms, Myanmar faces difficulties with the supply of antivenom, particularly in the rural areas [5]. Recently, it has been reported that antiserum used in the region of Myanmar displays lower efficacy against N. mandalayensis [3]. Considering that snakebite is a serious medical problem in rural areas of Myanmar and the data available on N. mandalayensis venom and envenomation is still scarce, and taking into account the relevance of understanding the biochemical composition of its venom, we have biochemically described, for the first time, the protein composition of its venom by using high performance liquid chromatography and mass spectrometry ESI-IT-TOF (proteomic) techniques.

Methods

Reagents

All reagents used in the present study are of analytical grade and obtained from Merck (Merck KGaA, Darmstadt, Germany and/or its affiliates), unless otherwise stated.

Venom attainment

A stablished partnership between Butantan Institute and the Ministry of Health of Myanmar, encompassed in a project called ‘Methods and techniques improvement for antivenom production in Myanmar’ granted us access to the pooled venom sample - from captivity individuals.

Sample preparation

The first step was to decomplex the venom in order to improve mass spectrometric analyses. Briefly, 10 mg lyophilized N. mandalayenses venom were resuspended in 0.1% Trifluoroacetic Acid (TFA) and centrifuged (10,000 x g) for 10 minutes, at 4ºC. The supernatant was then analyzed and fractionated by Reversed-Phase High Performance Liquid Chromatography (RP-HPLC) in a Shimadzu Prominence binary system (Shimadzu, Kyoto, Japan), coupled to a C18 analytical column (Supelco, 250 x 4.6 mm, 10 µm). UV detection was performed (SPDM 20A, Shimadzu, λ = 214 nm) and separation was achieved by a linear gradient of 0-40% solvent B (90% acetonitrile, containing 0.1% TFA) over A (0.1% TFA) for 40 minutes at a constant flow of 1 mL.min-1.

Mass spectrometry analyses

Manually collected fractions (50 µL aliquots) were submitted to in-solution digestion under the following conditions: (1) 5 µL DTT (100 mM dithiothreitol) were added for 30 minutes at 60ºC; (2) 2.5 µL of iodoacetamide (200 mM) added for another 30 minutes at room temperature and protected from light; (3) sample incubation for at least 12 hours at room temperature with 10 µL of trypsin (40 ng/µL in 100 mM ammonium bicarbonate). The reaction was stopped by adding 50% ACN/5% TFA. The samples then were analyzed by liquid chromatography-mass spectrometry in an ESI-IT-TOF instrument coupled to a UPLC 20A Prominence (Shimadzu, Kyoto, Japan). Samples (15 µL aliquots) were loaded into a C18 column (Kinetex C18, 5 μm; 50 × 2.1 mm) and fractionated by a binary gradient employing as solvents (A) water: DMSO: acid (949: 50: 1) and (B) ACN: DMSO: water: acid (850: 50: 99: 1). An elution gradient of 0-40% B was applied for 35 minutes at a constant flow of 0.2 mL.min-1 after initial isocratic elution for 5 minutes. The eluates were monitored by a Shimadzu SPD-M20A PDA detector before being injected into the mass spectrometer. The interface was kept at 4.5 kV and 275ºC. Detector operated at 1.95 kV and the argon collision induced fragmentation was set at 55 ‘energy’ value. MS spectra were acquired in positive mode, in the 350-1400 m/z range and MS/MS spectra were collected in the 50 to 1950 m/z range.

Proteomic data processing

Raw LCD LCMSolution Shimadzu data were converted into MGF by the LCMSolution (PRIDE) tool and then loaded into Peaks Studio V7.0 (BSI, Canada). Data were processed according to the following parameters: MS and MS/MS error mass were 0.1 Da; methionine oxidation and carbamidomethylation as variable and fixed modification, respectively; trypsin as cleaving enzyme; maximum missed cleavages (3), maximum variable PTMs per peptide (3) and non-specific cleavage (both); the false discovery rate was adjusted to ≤ 0.5%; only proteins with score ≥20 and containing at least 1 unique peptide were considered in this study. Data were analyzed against a Naja protein database (963 entries) compiled on January 2020 and built by retrieving all UniProt entries associated with this taxon, although broad searches against the whole UniProt were performed, as well, as quality controls (data not shown).

Results and discussion

Sample preparation is a critical step, required prior to any analytical step, particularly when the relative concentration range of the sample components is wide. One possible approach is to decomplex the sample by RP-HPLC [6]. In this work, we have chosen this approach in order to make it possible to identify both major toxins and minor components. Figure 1 presents the annotated RP-HPLC chromatogram, in which the proteomically identified proteins are indicated above the correspondent chromatographic fraction. It is possible to observe that the dynamic concentration range of toxins, in this particular venom, is very wide. For example, RT~35´ contains six abundant proteins, which detection saturated the UV signal, whereas RT ~5-25 contains sixteen minor proteins, which UV detection level was, at least, 15 times less intense than the largest signal. Thus, if shotgun proteomic strategy would be performed, less intense proteins would not likely be detected, as presented here. Although other sample preparation methods are available, such as batch-ion exchange chromatography [7], we have chosen to perform RP-HPLC based separation for our previous studies have demonstrated the non-viscous venoms can be efficiently fractionated by this technique [8, 9].
Figure 1.

C18-RP-HPLC representative profile of N. mandalayensis venom solution containing the fraction numbering as well as the toxin identification attained after the fraction proteomic processing.

Therefore, this decomplexation step - which was not intended to yield an ‘analytical’ profile, with the best possible resolution and signal to noise ratio - made it possible to normalize the protein contents in each individual fraction, leading to an optimal sample processing (reduction, alkylation and trypsinization) and consequent enhanced mass spectrometric detection of the normalized tryptic peptides. Following sample preparation and proteomic processing, N. mandalayeneses venom revealed itself to be a complex mixture of proteins (Figure 2). The UniProt GO molecular function annotation analyses led to the protein distribution presented in Figure 2A. Not surprising, more than half of the identified proteins fell into the ‘toxin’ category. In order to better understand these toxins, a second pie-chart graph was assembled analyzing only the ‘toxin’ keyword matched proteins (Figure 2B). This toxin distribution is in agreement with the recent work of Kazandjian et al. [10] that have elegantly studied the convergent evolution of the venom components of spitting cobras.
Figure 2.

(A) Relative protein distribution (according to their UniProt ‘molecular function’ identifier) of the proteomically identified proteins in N. mandalayensis venom. (B) Relative toxin (from ‘A’) distribution (according to their UniProt ‘mechanism of action’ identifier) of this proteomic subset.

Among the identified proteins, some known venom toxins could be detected. Namely: venom zinc metalloproteinase (SVMP) (Table 1), phospholipase A2 (PL A2), L-amino acid oxidase (LAAO), cysteine-rich venom protein (CRISP), venom 5-nucleotidase (V5N) and venom nerve growth factor (VNGF) (Table 2) [11, 12]. Moreover, other proteins, such as venom phosphodiesterase and NADH-related enzymes could be identified, also shown in Table 2. The complete list of the ‘other’ identified proteins is presented in the Additional file 1.
Table 1.

Known metallopeptidases matched to the proteomically identified toxins from N. mandalayensis venom.

DescriptionAccession-10lgP1 Peptides2 Avg. mass3 (Da)Organism4
Zinc metallopeptidase-disintegrin-like atraginD3TTC2319.72569181 N. atra
Zinc metallopeptidase-disintegrin-like cobrinQ9PVK7259.82367662 N. kaouthia
Hemorrhagic metallopeptidase-disintegrin-like kaouthiaginP82942256.81644493
Snake venom metallopeptidase-disintegrin-like mocarhaginQ10749249.92068176 N. mossambica
Zinc metallopeptidase-disintegrin-like kaouthiagin-likeD3TTC1237.42266292 N. atra
Zinc metallopeptidase-disintegrin-like atrase-AD5LMJ3214.42368254

1Peaks Suite confidence parameter. The cutoff was set > 50. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified.

Table 2.

Other known enzymes matched to the proteomically identified toxins from N. mandalayensis venom.

DescriptionAccession-10lgP1 Peptides2 Avg. mass3 (Da)Organism4
L-amino-acid oxidase A8QL58323.014357963 N. atra
Snake venom 5'-nucleotidase (Fragment)A0A2I4HXH5216.742558198
Venom phosphodiesteraseA0A2D0TC04186.342294616
Basic phospholipase A2 nigexineP1455656.76213340 N. pallida
A kinase anchor protein 9 K4GX1347.94447420 N. kaouthia
NADH-ubiquinone oxidoreductase chain 2 A9X4E042.95238341 N. naja
Q2V505238341 N. atra
A0A4P2VGL4237925 N. kaouthia
B6DCF5238321 N. atra
B6DA70238253
Q8W9X237.31238059 N. nivea
NADH-ubiquinone oxidoreductase chain 4 D9YM7835.69223869 N. arabica
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gammaA0A5B9CKM030.63237581 N. atra
A0A5B9CL15237581 N. kaouthia
A0A5B9CMR9237597 N. atra
NADH-ubiquinone oxidoreductase chain 4 A0A1W5PVT226.51124190 N. melanoleuca
A0A3G2KUZ9124434
A0A3G2KV06124390
A0A3G2KV13124450
A0A3G2KV16124420
A0A3G2KV47124445 N. peroescobari
NADH dehydrogenase subunit 4 A0A3G2KUY9124469 N. guineensis
A0A3G2KV04124481
A0A3G2KV05124481

1Peaks Suite confidence parameter. The cutoff was set > 25. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified.

1Peaks Suite confidence parameter. The cutoff was set > 50. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified. 1Peaks Suite confidence parameter. The cutoff was set > 25. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified. The pharmacological effect of the SVMPs in cobras has not been fully understood yet [13]. Few cobra SVMPs were biologically studied. Kaouthiagin (uniprot entry P82942) is an example: it seems to specifically bind to and cleave von Willebrand factor. In this sense, those authors speculate that this enzyme could be used as a pharmacological tool for functional studies of this factor [14]. Mocarhagin (Q10749) is another Naja SVMP that alters the clotting homeostasis [15]. But, in general, most cobra’s SVMPs have only been associated with platelet aggregation inhibition [16]. In the present work we have observed that - for N. mandalayensis - SVMPs were the most abundant (Figure 1) proteins identified among the hydrolases. The proteomic analyses (Table 1) show that these enzymes matched SVMPs from three different Naja species. It is interesting to mention that the high peptide count presented in Table 1 not only indicates that several peptides were detected in the MS analyses (protein quantity), but also that these peptides are fairly distributed throughout the protein (rather than matching only the active site, for example), indicating that there is some degree of protein homology among these species (Figure 3) [17, 18, 19].
Figure 3.

Coverage map representing the proteomic identification of SVMP (D3TTC2), according to Peaks Studio analyses. Blue bars represent the proteomically matched peptides, from N. mandalayensis venom, over the deposited sequence from N. atra. Letters ‘c’ and ‘o’ are the considered post-translation modifications selected for this analysis.

LAAO and PLA2 are commonly highlighted as enzymes of medical importance [20, 21] due to their abundance in the venom. These proteins are presented in Table 2, among others. The currently idenfied Naja LAAO (A8QL58) has little reported information regarding its pharmacological effects. Thus, this protein could present itself as an interesting molecule for further studies, for it is a remnant isoform from a diverse family of toxins. The here reported PLA2 (P14556), is similar to Nigexine - a basic phospholipase A2 from the venom of the spitting cobra Naja nigricollis - and may display an anticoagulant activity and affect the neuromuscular transmission [21, 22]. PLA2s from N. naja are considered lethal due to their neurotoxic activity, as previously observed in an experimental envenomation study [23]. Moreover, LAAOs, PLA2s and SVMPs have been associated to tissue inflammation and local necrosis of Elapidae snakes [24]. Also presented in Table 2 is the identification of Venom Phosphodiesterase (A0A2D0TC04) and V5N (A0A2I4HXH5), proteins that affect homeostasis and inhibit platelet aggregation induced by ADP, a consequence of both enzymes being able to degrade nucleotides [25-29]. According to Mitra and Bhattacharyya [30] who have isolated a phosphodiesterase from Daboia russelli venom with ADP hydrolytic activity, the platelet aggregation inhibition (in a human platelet rich plasma model) would be a consequence of the enzyme’s activity. Some toxins, on the other hand, do not display a defined role in the venom yet, such as Phosphatidylinositol-4,5-bisphosphate 3-kinase (A0A5B9CKM0), the NADH metabolism-related enzymes (Table 2) and A-kinase anchor protein 9 (K4GX13). Although the latter is directly related to the control of the production of reactive oxygen species in cardiac stress, responsible for cardiomyocyte dysfunction and death [31]. Nonetheless, the majority of the identified proteins in N. mandalayensis venom were three-finger toxins (3FTx, Figure 2B), particularly cytotoxins (Table 3) and neurotoxins (Table 4). Such abundance of 3FTx has been reported by other authors for related species [10]. In a work that describes the proteome of N. kaouthia and N. naja venom, 3FTx were the most representative toxins found in an Elapidae database [32].
Table 3.

Known 3FTx cytotoxins matched to the proteomically identified toxins from N. mandalayensis venom.

DescriptionAccession-10lgP1 Peptides2 Avg. mass3 (Da)Organism4
Cytotoxin 1P0145574.9836696 N. annulifera
Cytotoxin 1d/1e Q98958129.498992 N. atra
Cytotoxin 2P0144282.6449041
P01445150.256745 N. kaouthia
P0147474.4936850 N. melanoleuca
Cytotoxin 3P01446150.256717 N. kaouthia
Cytotoxin 4P0145290.9136715 N. mossambica
P0144382.6449084 N. atra
Cytotoxin 4NQ9W6W9103.959099
Cytotoxin 5P07525139.946810
Q98961128.649086
P24779132.566654 N. kaouthia
Cytotoxin 5aO7385782.6449041 N. sputatrix
Cytotoxin 5bP6031049055
Cytotoxin 6P80245136.388980 N. atra
Cytotoxin 7P86382118.666792 N. naja
P4912254.7249086 N. atra
Cytotoxin 8Q91124114.468900
P865409856793 N. naja
Cytotoxin 10 P8654178.1936764
Cytotoxin 11P6239450.3126842 N. haje haje
P6239026842 N. annulifera
Cytotoxin 13A0A0U4N5W4150.257947 N. naja
Cytotoxin SP15dP60309152.296652 N. atra
Cytotoxin 16A0A0U4W6K7132.177967 N. naja
Cytotoxin homologP1454183.2626994 N. kaouthia
Three-finger toxinE2ITZ4124.549139 N. atra
E2ITZ690.3659858
E2ITZ776.5438834

1Peaks Suite confidence parameter. The cutoff was set > 50. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified.

Table 4.

Known neurotoxins from 3FTx and CRISP families matched to the proteomically identified toxins from N. mandalayensis venom.

DescriptionAccession-10lgP1 Peptides2 Avg. mass3 (Da)Organism4
Cysteine-rich venom protein kaouthin-1P84805185.4926846 N. kaouthia
Cysteine-rich venom protein natrin-1Q7T1K6926882 N. atra
Cobrotoxin-bP80958124.549139
Cobrotoxin-cP59276136.846859 N. kaouthia
Short neurotoxin 1P6077446818 N. samarensis
P6077346873 N. philippinensis
Neurotoxin 5P6077246818 N. sputatrix
Weak neurotoxin NNAM2Q9YGI459.9239899 N. atra
Weak neurotoxin 5 O4225539806 N. sputatrix
Weak neurotoxin 6 O4225639807
Weak neurotoxin 8 Q802B339809
Weak neurotoxin 9 Q9W7I339836
Muscarinic toxin-like protein 2 P8246346.5537298 N. kaouthia

1Peaks Suite confidence parameter. The cutoff was set > 40. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified.

1Peaks Suite confidence parameter. The cutoff was set > 50. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified. 1Peaks Suite confidence parameter. The cutoff was set > 40. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified. In the present report, we could identify 19 different cytotoxins (Table 3) corresponding to approximately 45% (Figure 2B) of the toxins found. These molecules are also the ones displaying the largest presence of isoforms [33]. Their biological effects include systolic cardiac arrest and severe tissue necrosis, amongst others [34]. Moreover, most of these toxins are cytolytic to different cell lines, through a pore-forming activity on membranes. Nevertheless, their actual mechanism of action has not yet been completely elucidated [35]. The 3FTx neurotoxins (12 identifications, Table 4), accounted for about 32% of the toxins in the N. mandalayensis venom (Figure 2B). Elapid snake toxins are generally known to act on the nervous system, inhibiting the synaptic transmission by specifically and potently blocking a variety of ion channels, like Ca2+ and K+, as well as the nicotinic acetylcholine receptors [36, 37]. There are described CRISP toxins that also can behave as neurotoxins [38] by inhibiting Ca2+-activated K+ channels and voltage-gated K+ channels. Table 3 lists the 3FTx-neurotoxins found in the current work. In order to compare the present identified proteins groups/families and glimpse on their biological interest/relevance, we have compared the relative venom protein composition of N. mandalayensis venom with N. kaouthia, the closest phylogenetically relative according to Slowinski and Wüster [1]. This analysis is presented in Figure 4 and shows that homologous proteins display similar relative concentrations, such as acetylcholine receptor inhibitors, calcium channel inhibitors, platelet aggregation inhibitors and complement system inhibitors.
Figure 4.

Relative toxin concentration distribution (%) for N. mandalayensis (current work) and N. kaouthia (UniProt data) venoms. Classification terms based on the UniProt ‘mechanism of action’.

There were, however, N. kaouthia proteins that did not match any protein in the N. mandalayensis venom, such as ryanodine-sensitive calcium-release channel impairing and G-protein coupled acetylcholine receptor impairing. We cannot, though, relate the absence of these proteins - in the current study - to any actual lack of these proteins in N. mandalayensis venom. This event might be related to methodological/artefactual/biological phenomena that still need to be further explored. Noteworthy to mention is the high relative concentration of the cardiotoxins (3FTx) standing out for N. mandalayensis venom in comparison to N. kaouthia. A similar protein profile, however, has already been described for Ophiophagus hannah [25], a Malaysian king cobra. The transcriptome and proteome analyses revealed that 3FTx were the major venom component. O. hannah’s venom induces neurotoxicity and paralysis of the respiratory muscles and frequently provokes an extensive tissue necrosis and inflammation [25], similar to N. mandalayensis venom [2, 3]. Elapidae and Viperidae venoms have already been described to contain multiple peptidase inhibitors, most of them belonging to the Kunitz-type pancreatic trypsin inhibitors family [39,32]. Elapidae venoms, in particular, display strong inhibitory activity over mammalian serine peptidases, including trypsin, α-chymotrypsin, plasmin and kallikrein [40]. As presented in Figure 2A, peptidase inhibitors were also detected in the studied venom; however, at low levels (~1%). Nevertheless, due to the possible physo(patho)logical effects of peptidase inhibitors, we chose to present our findings regarding these molecules in Table 5. Two Kunitz-type serine protease inhibitor were detected and, according to Peaks Studio analyses, are identical (100% coverage, data not shown) to already sequence inhibitors from other Najas (P20229; P00986). Moreover, one cystatin already described for N. atra, (P81714), capable of inhibiting various cysteine proteases including cathepsin L, S, B and papain, were, also present in the venom[39]. However, in previous studies no toxic effects have been directly associated to these molecules [32].
Table 5.

Known peptidase inhibitors matched to the proteomically identified toxins from N. mandalayensis venom.

DescriptionAccession10lgP1 Peptides2 Avg. mass3 (Da)Organism4
Kunitz-type serine protease inhibitorP2022918776371 N. naja
Kunitz-type serine protease inhibitor 2P0098611736466 N. nivea
CystatinP8171420.33110995 N. atra

1Peaks Suite confidence parameter. The cutoff was set > 50. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified.

1Peaks Suite confidence parameter. The cutoff was set > 50. 2Matched peptides supporting the protein identification. 3Retrieved theoretical value. 4Species from which the matching toxins were identified.

Conclusion

The current work comprises the first characterization of the venom proteome of N. mandalayenses. The findings presented here will enhance future Naja venom comparative studies, as 86 N. mandalayensis proteins can now be encompassed in future research from proteomic and/or evolutionary perspectives. The selected approach, i.e., the initial venom fractionation by RP-HPLC, allowed mass spectrometric analyses optimization by removing the large concentration of the dynamic range variation naturally present in the venom, thus allowing the characterization of different toxins with high reliability. There are three major findings in the present study: (1) 3FTx are the major components of the venom; (2) SVMPs are the most diverse group of enzymes found, and; (3) the molecular diversity of the venom is likely to be a direct consequence of the venom spitting evolutionary strategy developed by N. mandalayensis, when compared other Naja venoms. Regarding the later observation, one can speculate that the most efficiently absorbed molecules (mucosa) would have been selected (as toxins) throughout evolution, such as the cardiotoxins here reported (Figure 2B). The current proteome description should help shed a light on the evolutionary and phylogenetic relations between N. mandalayenses and other Naja, since the current species, although geographically limited to southeastern Asia and consequently related to the Asian non-spitting cobras, has adopted the spitting strategy present either on the insular southeastern countries or in the African elapids.
  37 in total

1.  Purification and characterization of phosphodiesterase (exonuclease) from Cerastes cerastes (Egyptian sand viper) venom.

Authors:  H Y Halim; E A Shaban; M M Hagag; E W Daoud; M F el-Asmar
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

Review 2.  Venom ophthalmia caused by venoms of spitting elapid and other snakes: Report of ten cases with review of epidemiology, clinical features, pathophysiology and management.

Authors:  Edward R Chu; Scott A Weinstein; Julian White; David A Warrell
Journal:  Toxicon       Date:  2010-03-21       Impact factor: 3.033

3.  Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naha kaouthia cobra venom.

Authors:  J Hamako; T Matsui; S Nishida; S Nomura; Y Fujimura; M Ito; Y Ozeki; K Titani
Journal:  Thromb Haemost       Date:  1998-09       Impact factor: 5.249

4.  Clinical importance of the Mandalay spitting cobra (Naja mandalayensis) in Upper Myanmar - Bites, envenoming and ophthalmia.

Authors:  Mark O'Shea; Mohammad Afzal Mahmood; Chen Au Peh; Julian White; David A Warrell
Journal:  Toxicon       Date:  2020-06-03       Impact factor: 3.033

5.  Neuromuscular effects of nigexine, a basic phospholipase A2 from Naja nigricollis venom.

Authors:  E G Rowan; A L Harvey; A Menez
Journal:  Toxicon       Date:  1991       Impact factor: 3.033

6.  Africanized honey bee (Apis mellifera) venom profiling: Seasonal variation of melittin and phospholipase A(2) levels.

Authors:  Rui S Ferreira Junior; Juliana M Sciani; Rafael Marques-Porto; Airton Lourenço Junior; Ricardo de O Orsi; Benedito Barraviera; Daniel C Pimenta
Journal:  Toxicon       Date:  2010-04-18       Impact factor: 3.033

7.  Cobra venom contains a pool of cysteine-rich secretory proteins.

Authors:  Alexey V Osipov; Mikhail Yu Levashov; Victor I Tsetlin; Yuri N Utkin
Journal:  Biochem Biophys Res Commun       Date:  2005-03-04       Impact factor: 3.575

8.  Nigexine, a phospholipase A2 from cobra venom with cytotoxic properties not related to esterase activity. Purification, amino acid sequence, and biological properties.

Authors:  S Chwetzoff; S Tsunasawa; F Sakiyama; A Ménez
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

9.  Comparison of the primary structures, cytotoxicities, and affinities to phospholipids of five kinds of cytotoxins from the venom of Indian cobra, Naja naja.

Authors:  Mieko Suzuki-Matsubara; Senarath B P Athauda; Yoshiyuki Suzuki; Kazumi Matsubara; Akihiko Moriyama
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-10-09       Impact factor: 3.228

10.  First Look at the Venom of Naja ashei.

Authors:  Konrad Kamil Hus; Justyna Buczkowicz; Vladimír Petrilla; Monika Petrillová; Andrzej Łyskowski; Jaroslav Legáth; Aleksandra Bocian
Journal:  Molecules       Date:  2018-03-08       Impact factor: 4.411

View more
  2 in total

1.  Compositional and toxicological investigation of pooled venom from farm-raised Naja atra.

Authors:  Gang Xiao; Junqi Liu; Lingfeng Peng; Yang Yang; Zhiliang Sun
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2022-03-14

2.  The myth of cobra venom cytotoxin: More than just direct cytolytic actions.

Authors:  Jia Jin Hiu; Michelle Khai Khun Yap
Journal:  Toxicon X       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.